Good day. Welcome to the SBC Medical Group Holdings, Incorporated. annual meeting of stockholders. I will now turn the call over to Yoshiyuki Aikawa, CEO and Chairman. Please go ahead. Hello, everyone. Welcome to the 2026 annual stockholders meeting of SBC Medical Group Holdings, Incorporated. I am Yoshiyuki Aikawa, CEO and Chairman of SBC Medical Group Holdings, Incorporated. I will serve as chairman of this meeting. It is my pleasure to welcome you here today for this meeting. We are excited to be hosting our meeting in virtual format, which allows us to be more inclusive and reach a greater number of our stockholders. It is now 9:00 A.M., Japan Standard Time. This meeting is officially called to order. Today, I am joined by our other current directors, Mr. Yuya Yoshida, who is also our Chief Financial Officer and Chief Operating Officer, Mr. Ken Edahiro, Mr. Mike Sayama, and Mr. Fumitoshi Fujiwara. I am also joined by our head of legal, Kotaro Okamoto, who will act as secretary of the meeting. Thank you, Dr. Aikawa. We are also joined here today by [Wendell Guo] and Jaddy Wang, representatives of MaloneBailey, LLP, our independent auditors. They will be available during the question-and-answer session after the meeting to respond to appropriate questions. Finally, Christina Kadirov of the Career Group joins us today and will act as Inspector of Election, partner to our Executive Officer Inspector. During the formal meeting, we will first address some housekeeping items before presenting the seven proposals subject to a vote, which are described in the company's proxy statement, dated May 28th, 2026. You will have the opportunity to ask questions on the proposals after presentation. After the formal meeting has been adjourned, we will provide some time for general questions. Only validated stockholders may ask questions in the designated field on the web portal. Out of consideration for others, please limit yourself to two questions. Please note that this meeting is being recorded and will be posted to our company website. However, no one attending via the webcast or telephone is permitted to use any audio recording device. Additional expectations for the conduct of this meeting are contained in the rules and procedures for the conduct of the annual meeting, which are posted to the virtual meeting page. We kindly request all participants to abide by these parameters. Finally, I would like to point out that some of our discussion today may include forward-looking statements. Forward-looking statements are statements about, among other things, financial projections, managerial plans or objectives, or future economic performance. Actual results may differ materially from those projected by any forward-looking statements. Please refer to our latest SEC filings for a discussion of risks that may cause future events to differ from our current expectations. The board of directors fixed May 28, 2026, as the record date for determining stockholders entitled to vote at this meeting. The company has received an affidavit of distribution that documents the commencement of mailing of the proxy materials on May 28th, 2026, and will be incorporated into the minutes of this meeting, along with the notice of meeting. The stockholder list shows that as of the record date, there were 102,576,943 shares of common stock outstanding, entitled to vote this meeting. The Inspector of Election has informed us that there were represented in person or by proxy shares of common stock representing the majority of all outstanding stock entitled to vote at the meeting. Therefore, quorum is present for purposes of transaction in business, and this meeting is duly convened. Now Dr. Aikawa will open the polls. The polls are now open, and you are able to vote during this meeting until I close the polls following the presentation of our seven proposals. Remember, if you already voted in advance online or by telephone or physical proxy card, you don't need to vote again, and a vote at this meeting will supersede your earlier vote. Now I present the matters to be voted upon. Proposal one is the election of directors. Our board of directors nominated Yoshiyuki Aikawa, Yuya Yoshida, Ken Edahiro, and Fumitoshi Fujiwara for election at the annual meeting to hold office until the 2027 annual meeting of stockholders, or until their successors are duly elected and qualified. Proposal two is ratification of appointment of MaloneBailey, LLP as our independent registered public accounting firm for the 2026 fiscal year. This is a non-binding proposal. Proposal three is amendment of our current charter to eliminate the plurality voting requirement for the election of directors. Proposal four is amendment of our current charter to eliminate the provision stating directors may be removed only for cause. Proposal five is amendment of our current charter to opt out of Section 203 of the Delaware General Corporation Law. Proposal six is amendment of our current charter to provide for exculpation of officers. Proposal seven is other technical amendments to our current charter. For the reasons outlined in the proxy statement, our board of directors recommends a vote for to each of the director nominees and proposals two, three, four, five, six, and seven. There are no additional candidates or proposals that have been properly brought before the meeting. Does anyone have questions concerning any of the seven proposals presented? Any stockholder who haven't yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instruction there. Stockholders who have sent instructions or voted via telephone or internet and do not want to change their vote do not need to take any further action. If you wish to vote on the seven proposals and have not submitted your vote, please do so now. After three votes, Dr. Aikawa will close the polls. Now that everyone has had the opportunity to vote, I now declare the polls for the 2026 Annual Stockholders Meeting closed. We have been informed by the Inspector of Election that the preliminary vote report shows that the nominees for election to the board have been duly elected. Appointment of MaloneBailey, LLP as independent registered accounting firm has been ratified, and all of the proposals related to the amendment of our current charter have been approved. We will be reporting the final vote results in a Form 8-K to be filed within four business days. With that done, I turn the meeting over to our CEO. Thank you, Kotaro. There being no further business to come before the meeting, the official portion of the 2026 Annual Meeting of Stockholders of SBC Medical Group Holdings, Incorporated is now adjourned. Stockholders will have the opportunity to ask questions. Please note we'll attempt to answer as many questions as time allows, but we'll only address questions that are relevant to the meeting. There seems to be no questions. That concludes our meeting. We thank you for your attendance today and continued support. Now you may disconnect. The conference has now concluded, and we thank you for attending today's presentation. You may now disconnect your lines.